BioNTech SE
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. BioNTech SE's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 78% to $3,819,000,000. The net income dropped to $930,300,000 and profit margin reached 24%. Total operating expenses were $2,528,800,000.

Profit Margin

BioNTech SE (NASDAQ:BNTX): Profit margin
2017 61.59M -85.65M -139.05%
2018 127.57M -48.01M -37.64%
2019 108.58M -179.17M -165%
2020 482.32M 15.2M 3.15%
2021 18.97B 10.29B 54.24%
2022 17.31B 9.43B 54.5%
2023 3.81B 930.3M 24.36%

BNTX Income Statement (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue
3.81B17.31B18.97B482.32M108.58M127.57M61.59M
Cost of revenue
599.8M4.53B3.86B704.36M243.82M156.73M94.81M
Gross profit
3.21B12.77B15.11B-222.03M-135.23M-29.15M-33.21M
Operating exp.
Research and development
1.78B116M102.7M645.02M226.46M143.04M85.49M
Selling and marketing
62.7M59.5M50.4M14.51M2.71M3.04M6.60M
Total operating expenses
2.52B135.9M200.1M-139.62M46.28M24.69M28.06M
Operating income
690.4M12.64B15.28B-82.41M-181.51M-53.85M-61.27M
Other income (expenses), net
495.7M311.4M-237.4M-63.4M2.07M5.96M-24.62M
Income before tax
1.18B12.95B15.04B-145.80M-179.44M-47.66M-85.90M
Income tax expense
255.8M3.51B4.75B-161M-268K600K45K
Net income
930.3M9.43B10.29B15.2M-179.17M-48.01M-85.65M
Earnings per share
Basic EPS
3.8338.0843.870.06-0.85-0.21-0.38
Diluted EPS
3.8337.0941.210.05-0.85-0.21-0.38
Data sourceData sourceData sourceData sourceData source